News · More Shionogi & Co., Ltd. news

Shionogi & Co., Ltd. TSE:4507

Shionogi Announces Supplemental Approval in Japan for Pediatric Dosage and Administration of XOCOVA to Treat COVID-19

Published June 19, 2026 at 5:00 a.m. UTC

Source: TDnet

Shionogi & Co., Ltd. (4507) Press Release

View Attachment